[Federal Register: April 2, 2009 (Volume 74, Number 62)]
[Notices]
[Page 15009-15010]
[DOCID:fr02ap09-88]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

Submission for OMB Review; Comment Request

Upon Written Request; Copies Available From: Securities and Exchange
Commission, Office of Investor Education and Advocacy, Washington, DC
20549-0213.

Extension:
    Form TH; OMB Control No. 3235-0425; SEC File No. 270-377.

    Notice is hereby given that, pursuant to the Paperwork Reduction
Act of 1995 (44 U.S.C. 3501 et seq.), the Securities and Exchange
Commission (``Commission'') has submitted to the Office of Management
and Budget a request for extension of the previously approved
collection of information discussed below.
    Form TH (17 CFR 239.65, 249.447, 269.10 and 274.404) under the
Securities Act of 1933 (15 U.S.C. 77a et seq.), the Securities Exchange
Act of 1934 (15 U.S.C. 78a et seq.), the Trust Indenture Act of 1939
(15 U.S.C. 77aaa et seq.) and the Investment Company Act of 1940 (15
U.S.C. 80a-1 et seq.) is used by registrants to notify the Commission
that an electronic filer is relying on the temporary hardship exemption
for the filing of a document in paper format that would otherwise be
required to be filed electronically as prescribed by Rule 201(a) of
Regulation S-T (17 CFR 232.201(a)). Form TH is a public document and is
filed on occasion. Form TH must be filed every time an electronic filer
experiences unanticipated technical difficulties preventing the timely
preparation and submission of a required electronic filing.
Approximately 70 registrants file Form TH and it takes an estimated
0.33 hours per response for a total estimated annual burden of 23
hours.
    An agency may not conduct or sponsor, and a person is not required
to respond to, a collection of information unless it displays a
currently valid control number.
    Written comments regarding the above information should be directed
to the following persons: (i) Desk Officer for the Securities and
Exchange Commission, Office of Information and Regulatory Affairs,
Office of Management and Budget, Room 10102, New Executive Office
Building, Washington, DC 20503; or send an e-mail to Shagufta_
<EMAIL_ADDRESS>(ii) Charles Boucher, Director/CIO, Securities and
Exchange Commission, C/O Shirley Martinson, 6432 General Green Way,
Alexandria, VA 22312; or send an e-mail to:

<EMAIL_ADDRESS>Comments must be submitted to OMB within 30 days
of this notice.

    Dated: March 27, 2009.
Florence E. Harmon,
Deputy Secretary.
[FR Doc. E9-7355 Filed 4-1-09; 8:45 am]

BILLING CODE 8010-01-P


[Federal Register Volume 84, Number 136 (Tuesday, July 16, 2019)]
[Rules and Regulations]
[Pages 33850-33853]
[FR Doc No: 2019-14879]

=======================================================================
-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

40 CFR Part 52

[EPA-R04-OAR-2017-0422; FRL-9996-43-Region 4]

Air Plan Approval; NC; Emission Control Standards, Open Burning,
and Miscellaneous Revisions

AGENCY: Environmental Protection Agency (EPA).

ACTION: Final rule.

-----------------------------------------------------------------------

SUMMARY: The Environmental Protection Agency (EPA) is taking final
action to approve portions of a revision to the North Carolina State
Implementation Plan (SIP) submitted by the State of North Carolina
through the North Carolina Department of Environmental Quality
(formerly the North Carolina Department of Environment and Natural
Resources (NCDENR)), Division of Air Quality, on January 31, 2008. The
revision includes changes to emission control standards and open
burning regulations. The changes are part of North Carolina's strategy
to meet and

maintain the national ambient air quality standards (NAAQS). This
action is being taken pursuant to the Clean Air Act (CAA or Act) and
its implementing regulations.

DATES: This rule is effective August 15, 2019.

ADDRESSES: EPA has established a docket for this action under Docket
Identification No. EPA-R04-OAR-2017-0422. All documents in the docket
are listed on the www.regulations.gov website. Although listed in the
index, some information is not publicly available, i.e., Confidential
Business Information or other information whose disclosure is
restricted by statute. Certain other material, such as copyrighted
material, is not placed on the internet and will be publicly available
only in hard copy form. Publicly available docket materials are
available either electronically through www.regulations.gov or in hard
copy at the Air Regulatory Management Section, Air Planning and
Implementation Branch, Air and Radiation Division (formerly the Air,
Pesticides and Toxics Management Division), U.S. Environmental
Protection Agency, Region 4, 61 Forsyth Street SW, Atlanta, Georgia
30303-8960. EPA requests that if at all possible, you contact the
person listed in the FOR FURTHER INFORMATION CONTACT section to
schedule your inspection. The Regional Office's official hours of
business are Monday through Friday 8:30 a.m. to 4:30 p.m., excluding
Federal holidays.

FOR FURTHER INFORMATION CONTACT: Andres Febres, Air Regulatory
Management Section, Air Planning and Implementation Branch, Air and
Radiation Division, U.S. Environmental Protection Agency, Region 4, 61
Forsyth Street SW, Atlanta, Georgia 30303-8960. The telephone number is
(404) 562-8966. Mr. Febres can also be reached via electronic mail at
<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION:

I. Background

    On January 31, 2008, the State of North Carolina, through
NCDENR,\1\ submitted changes to the North Carolina SIP for EPA
approval. EPA is taking final action to approve changes to the
following regulations under 15A North Carolina Administrative Code
(NCAC) 02D: Section .0519, Control of Nitrogen Dioxide and Nitrogen
Oxides Emissions; Section .0540, Particulates From Fugitive Non-Process
Dust Emission Sources; and Section .1907, Multiple Violations Arising
From a Single Episode.\2\ These changes are a part of North Carolina's
strategy to attain and maintain the NAAQS and are being approved
pursuant to section 110 of the CAA. EPA has taken, will take, or, for
various reasons, will not take separate action on all other changes
submitted on January 31, 2008.\3\
---------------------------------------------------------------------------

    \1\ NCDENR is now the North Carolina Department of Environmental
Quality.
    \2\ In the table of North Carolina regulations federally
approved into the SIP at 40 CFR 52.1770(c), 15A NCAC 02D is referred
to as ``Subchapter 2D Air Pollution Control Requirements.''
    \3\ On February 5, 2015 (80 FR 6455), EPA took final action on
2D Section .1004. On July 18, 2017 (82 FR 32767), EPA took direct
final action on 2D Sections .1901, .1902 and .1903. EPA will be
taking separate action on 15A NCAC Sections 2D .1904 and 2Q .0102.
EPA is not taking action on 2D Sections .0516 and .0521, because the
changes to these rules reference incinerator rules under CAA
sections 111(d) and 129 and 40 CFR part 60 and are not a part of the
federally-approved SIP. EPA is not taking action on changes to 2Q
Section .0506 because the proposed changes reference a regulation
not approved into the SIP and which is being repealed by North
Carolina. Lastly, EPA is not taking action on changes to 2D Sections
.0524, .0960, .1201, .1202, .1208, .1211, and .2303 because the
State withdrew these regulations from its January 31, 2008,
submittal.
---------------------------------------------------------------------------

    The revisions that are the subject of this final action make
changes to emission control standard regulations under Subchapter 2D of
the North Carolina SIP. These changes revise the applicability of
nitrogen dioxide (NO2) and nitrogen oxides emissions
standards to nitric acid plants; amend definitions and expand the
applicability of provisions related to fugitive dust emissions,
including renaming the rule to eliminate the word ``non-process''; and
add a new open burning rule for multiple violations that can occur from
a single open burning event. The changes either do not interfere with
attainment and maintenance of the NAAQS or they have the effect of
strengthening the North Carolina SIP. In a notice of proposed
rulemaking (NPRM) published on March 11, 2019 (84 FR 8654), EPA
proposed to approve the aforementioned revisions to the North Carolina
SIP. The NPRM provides additional detail regarding the background and
rationale for EPA's action. Comments on the NPRM were due on or before
April 10, 2019. EPA received one comment on the proposed action, but it
is not germane to the proposed action. That comment is discussed below.

II. Response to Comments

    EPA received one comment, which addresses portions of North
Carolina's submittal on which EPA is not acting in this rulemaking. The
comment concerns changes to 15A NCAC 02D .0521 and .1201, as well as
the adoption of 15A NCAC 02D .1211. As explained herein and in the
NPRM, see 84 FR at 8655 n.3, those NCAC provisions are not the subject
of this rulemaking, and EPA is not taking action on changes to them.
Therefore, the comment is not relevant to this action.

III. Incorporation by Reference

    In this rule, EPA is finalizing regulatory text that includes
incorporation by reference. In accordance with requirements of 1 CFR
51.5, EPA is finalizing the incorporation by reference of state
regulations under Subchapter 2D Air Pollution Control Requirements,
Section .0519, Control of Nitrogen Dioxide and Nitrogen Oxides
Emissions; and Section .1907, Multiple Violations Arising from a Single
Episode, which have a state effective date of July 1, 2007; as well as
Section .0540, Particulates From Fugitive Dust Emission Sources, which
has as effective date of August 1, 2007. EPA has made, and will
continue to make, these materials generally available through
www.regulations.gov and at the EPA Region 4 Office (please contact the
person identified in the FOR FURTHER INFORMATION CONTACT section of
this preamble for more information). Therefore, these materials have
been approved by EPA for inclusion in the SIP, have been incorporated
by reference by EPA into that plan, are fully federally enforceable
under sections 110 and 113 of the CAA as of the effective date of the
final rulemaking of EPA's approval, and will be incorporated by
reference in the next update to the SIP compilation.\4\
---------------------------------------------------------------------------

    \4\ See 62 FR 27968 (May 22, 1997).
---------------------------------------------------------------------------

IV. Final Action

    For the reasons described above, EPA is taking final action to
approve the aforementioned changes to the North Carolina SIP submitted
by the State of North Carolina on January 31, 2008, pursuant to CAA
section 110 because these changes are consistent with the CAA. Changes
to the other sections in these submissions have been or will be
processed in a separate action, as appropriate, for approval into the
North Carolina SIP.

V. Statutory and Executive Order Reviews

    Under the CAA, the Administrator is required to approve a SIP
submission that complies with the provisions of the Act and applicable
Federal regulations. See 42 U.S.C. 7410(k); 40 CFR 52.02(a). Thus, in
reviewing SIP submissions, EPA's role is to approve state choices,
provided that they meet the criteria of

the CAA. This action merely approves state law as meeting Federal
requirements and does not impose additional requirements beyond those
imposed by state law. For that reason, this action:
     Is not a significant regulatory action subject to review
by the Office of Management and Budget under Executive Orders 12866 (58
FR 51735, October 4, 1993) and 13563 (76 FR 3821, January 21, 2011);
     Is not an Executive Order 13771 (82 FR 9339, February 2,
2017) regulatory action because SIP approvals are exempted under
Executive Order 12866;
     Does not impose an information collection burden under the
provisions of the Paperwork Reduction Act (44 U.S.C. 3501 et seq.);
     Is certified as not having a significant economic impact
on a substantial number of small entities under the Regulatory
Flexibility Act (5 U.S.C. 601 et seq.);
     Does not contain any unfunded mandate or significantly or
uniquely affect small governments, as described in the Unfunded
Mandates Reform Act of 1995 (Pub. L. 104-4);
     Does not have Federalism implications as specified in
Executive Order 13132 (64 FR 43255, August 10, 1999);
     Is not an economically significant regulatory action based
on health or safety risks subject to Executive Order 13045 (62 FR
19885, April 23, 1997);
     Is not a significant regulatory action subject to
Executive Order 13211 (66 FR 28355, May 22, 2001);
     Is not subject to requirements of Section 12(d) of the
National Technology Transfer and Advancement Act of 1995 (15 U.S.C. 272
note) because application of those requirements would be inconsistent
with the CAA; and
     Does not provide EPA with the discretionary authority to
address, as appropriate, disproportionate human health or environmental
effects, using practicable and legally permissible methods, under
Executive Order 12898 (59 FR 7629, February 16, 1994).
    The SIP is not approved to apply on any Indian reservation land or
in any other area where EPA or an Indian tribe has demonstrated that a
tribe has jurisdiction. In those areas of Indian country, the rule does
not have tribal implications as specified by Executive Order 13175 (65
FR 67249, November 9, 2000), nor will it impose substantial direct
costs on tribal governments or preempt tribal law.
    The Congressional Review Act, 5 U.S.C. 801 et seq., as added by the
Small Business Regulatory Enforcement Fairness Act of 1996, generally
provides that before a rule may take effect, the agency promulgating
the rule must submit a rule report, which includes a copy of the rule,
to each House of the Congress and to the Comptroller General of the
United States. EPA will submit a report containing this action and
other required information to the U.S. Senate, the U.S. House of
Representatives, and the Comptroller General of the United States prior
to publication of the rule in the Federal Register. A major rule cannot
take effect until 60 days after it is published in the Federal
Register. This action is not a ``major rule'' as defined by 5 U.S.C.
804(2).
    Under section 307(b)(1) of the CAA, petitions for judicial review
of this action must be filed in the United States Court of Appeals for
the appropriate circuit by September 16, 2019. Filing a petition for
reconsideration by the Administrator of this final rule does not affect
the finality of this action for the purposes of judicial review nor
does it extend the time within which a petition for judicial review may
be filed, and shall not postpone the effectiveness of such rule or
action. This action may not be challenged later in proceedings to
enforce its requirements. See section 307(b)(2).

List of Subjects in 40 CFR Part 52

    Environmental protection, Air pollution control, Carbon monoxide,
Incorporation by reference, Intergovernmental relations, Lead, Nitrogen
dioxide, Ozone, Particulate matter, Reporting and recordkeeping
requirements, Sulfur oxides, Volatile organic compounds.

    Authority: 42 U.S.C. 7401 et seq.

    Dated: June 26, 2019.
Mary S. Walker,
Regional Administrator, Region 4.

    40 CFR part 52 is amended as follows:

PART 52--[APPROVAL AND PROMULGATION OF IMPLEMENTATION PLANS]

0
1. The authority citation for part 52 continues to read as follows:

    Authority: 42 U.S.C. 7401 et seq.

Subpart II--North Carolina

0
2. In Sec.  52.1770, the table in paragraph (c)(1) is amended under
Subchapter 2D Air Pollution Control Requirements by:
0
a. Revising the entries for ``Section .0519'' and ``Section .0540'';
and
0
b. Adding an entry for ``Section .1907'' in numerical order.
    The revisions and addition read as follows:

Sec.  52.1770  Identification of plan.

* * * * *
    (c) * * *

                                   (1) EPA Approved North Carolina Regulations
----------------------------------------------------------------------------------------------------------------
                                                      State
       State citation           Title/subject    effective date   EPA approval date          Explanation
----------------------------------------------------------------------------------------------------------------
                                Subchapter 2D Air Pollution Control Requirements
----------------------------------------------------------------------------------------------------------------

                                                  * * * * * * *
----------------------------------------------------------------------------------------------------------------
                                    Section .0500 Emission Control Standards
----------------------------------------------------------------------------------------------------------------

                                                  * * * * * * *
Section .0519..............  Control of                7/1/2007  7/16/2019 [Insert
                              Nitrogen Dioxide                    citation of
                              and Nitrogen                        publication].
                              Oxides Emissions.

                                                  * * * * * * *
Section .0540..............  Particulates from         8/1/2007  7/16/2019 [Insert
                              Fugitive Dust                       citation of
                              Emission Sources.                   publication].

                                                  * * * * * * *
----------------------------------------------------------------------------------------------------------------
                                           Section .1900 Open Burning
----------------------------------------------------------------------------------------------------------------

                                                  * * * * * * *
Section .1907..............  Multiple                  7/1/2007  7/16/2019 [Insert
                              Violations                          citation of
                              Arising from a                      publication].
                              Single Episode.

                                                  * * * * * * *
----------------------------------------------------------------------------------------------------------------

* * * * *
[FR Doc. 2019-14879 Filed 7-15-19; 8:45 am]
BILLING CODE 6560-50-P


[Federal Register Volume 88, Number 67 (Friday, April 7, 2023)]
[Rules and Regulations]
[Pages 20754-20760]
[FR Doc No: 2023-07134]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

14 CFR Part 39

[Docket No. FAA-2022-1661; Project Identifier MCAI-2022-00714-T;
Amendment 39-22380; AD 2023-05-11]
RIN 2120-AA64

Airworthiness Directives; Bombardier, Inc., Airplanes

AGENCY: Federal Aviation Administration (FAA), DOT.

ACTION: Final rule.

-----------------------------------------------------------------------

SUMMARY: The FAA is adopting a new airworthiness directive (AD) for
certain Bombardier, Inc., Model BD-700-1A10 and BD-700-1A11 airplanes.
This AD was prompted by a report that in case of a flap, slat, or slat-
flap failure in flight, resetting the slat flap control unit (SFCU) to
clear the error using the airplane flight manual (AFM) could result in
the stall protection computer (SPC) setting the low-speed cue to the
most conservative stall advance mode. This AD requires revising the
non-normal procedures section of the existing AFM to provide the
flightcrew with procedures for addressing failure warnings in the slat
and flap control systems. The FAA is issuing this AD to address the
unsafe condition on these products.

DATES: This AD is effective May 12, 2023.
    The Director of the Federal Register approved the incorporation by
reference of certain publications listed in this AD as of May 12, 2023.

ADDRESSES:
    AD Docket: You may examine the AD docket at regulations.gov under
Docket No. FAA-2022-1661; or in person at Docket Operations between 9
a.m. and 5 p.m., Monday through Friday, except Federal holidays. The AD
docket contains this final rule, the mandatory continuing airworthiness
information (MCAI), any comments received, and other information. The
address for Docket Operations is U.S. Department of Transportation,
Docket Operations, M-30, West Building Ground Floor, Room W12-140, 1200
New Jersey Avenue SE, Washington, DC 20590.
    Material Incorporated by Reference:
     For service information identified in this final rule,
contact Bombardier Business Aircraft Customer Response Center, 400
C[ocirc]te-Vertu Road West, Dorval, Qu[eacute]bec H4S 1Y9, Canada;
telephone<PHONE_NUMBER>; email bombardier.com">[email protected]bombardier.com; website
bombardier.com.
     You may view this service information at the FAA,
Airworthiness Products Section, Operational Safety Branch, 2200 South
216th St., Des Moines, WA. For information on the availability of this
material at the FAA, call<PHONE_NUMBER>. It is also available at
regulations.gov under Docket No. FAA-2022-1661.

FOR FURTHER INFORMATION CONTACT: Elizabeth Dowling, Aerospace Engineer,
Mechanical Systems and Administrative Services Section, FAA, New York
ACO Branch, 1600 Stewart Avenue, Suite 410, Westbury, NY 11590;
telephone<PHONE_NUMBER>; email [email protected].

SUPPLEMENTARY INFORMATION:

Background

    The FAA issued a notice of proposed rulemaking (NPRM) to amend 14
CFR part 39 by adding an AD that would apply to certain Bombardier,
Inc., Model BD-700-1A10 and BD-700-1A11 airplanes. The NPRM published
in the Federal Register on January 13, 2023 (88 FR 2286). The NPRM was
prompted by AD CF-2022-30, dated June 3, 2022, (referred to after this
as the MCAI) issued by Transport Canada, which is the aviation
authority for Canada. The MCAI states in case of a flap, slat, or slat-
flap failure in flight, resetting the SFCU to clear the error using the
AFM could result in the SPC setting the low-speed cue to the most
conservative stall advance mode instead of that published in the AFM.
This condition could result in unexpected stall warnings (aural and
visual) as well as stick shaker activation during approach for a
landing, increasing flightcrew workload during a critical phase of
flight. The higher landing speed could consequently require a greater
landing distance and possible diversion to a longer runway.
    In the NPRM, the FAA proposed to require revising the non-normal
procedures section of the existing AFM to provide the flightcrew with
procedures for addressing failure warnings in the slat and flap control
systems. The FAA is issuing this AD to address the unsafe condition on
these products.
    You may examine the MCAI in the AD docket at regulations.gov under
Docket No. FAA-2022-1661.

Discussion of Final Airworthiness Directive

Comments

    The FAA received no comments on the NPRM or on the determination of
the cost to the public.

Conclusion

    This product has been approved by the aviation authority of another
country and is approved for operation in the United States. Pursuant to
the FAA's bilateral agreement with this State of Design Authority, it
has notified the FAA of the unsafe condition described in the MCAI
referenced above. The FAA reviewed the relevant data and determined
that air safety requires adopting this AD as proposed. Accordingly, the
FAA is issuing this AD to address the unsafe condition on this product.
Except for minor editorial changes, this AD is adopted as proposed in
the NPRM. None of the changes will increase the economic burden on any
operator.

Related Service Information Under 1 CFR Part 51

    The FAA reviewed the following Bombardier service information. This
service information specifies procedures for revising the non-normal
procedures section of the existing AFM to provide the flightcrew with
procedures for addressing failure warnings in the slat and flap control
systems. These documents are distinct since they apply to different
airplane models.
     C. Flap Fail (Caution), D. Slat Fail (Caution), E. Slat-
Flap Fail (Caution), and F. Slat Fault (Caution) or Flap Fault
(Caution) or Slat-Flap Fault (Caution) procedures of the Slat and Flap
Control System, Section 05-10, Flight Controls, Chapter 5--Non Normal
Procedure, of the Bombardier Global Express AFM, Publication No. CSP
700-1, Revision 112, dated May 19, 2022. (For obtaining the procedures
for Bombardier Global Express AFM, Publication No. CSP 700-1, use
Document Identification No. GL 700 AFM-1.)
     C. Flap Fail (Caution), D. Slat Fail (Caution), E. Slat-
Flap Fail (Caution), and F. Slat Fault (Caution) or Flap Fault
(Caution) or Slat-Flap Fault (Caution) procedures of the Slat and Flap
Control System, Section 05-10, Flight Controls, Chapter 5--Non Normal
Procedure, of the Bombardier Global Express XRS AFM, Publication No.
CSP 700-1A, Revision 112, dated May 19, 2022. (For obtaining the
procedures for Bombardier Global Express XRS AFM, Publication No. CSP
700-1A, use Document Identification No. GL 700 AFM-1A.)
     C. Flap Fail (Caution), D. Slat Fail (Caution), E. Slat-
Flap Fail (Caution), and F. Slat Fault (Caution) or Flap Fault
(Caution) or Slat-Flap Fault (Caution) procedures of the Slat and Flap
Control System, Section 05-10, Flight Controls, Chapter 5--Non Normal
Procedure, of the Bombardier Global 5000 AFM, Publication No. CSP 700-
5000-1, Revision 73, dated May 19, 2022. (For obtaining the procedures
for Bombardier Global Express AFM, Publication No. CSP 700-5000-1, use
Document Identification No. GL 5000 AFM.)
     C. Flap Fail (Caution), D. Slat Fail (Caution), E. Slat-
Flap Fail (Caution), and F. Slat Fault (Caution) or Flap Fault
(Caution) or Slat-Flap Fault (Caution) procedures of the Slat and Flap
Control System, Section 05-10, Flight Controls, Chapter 5--Non Normal
Procedure, of the Bombardier Global 5000 AFM, Publication No. CSP 700-
5000-1V, Revision 42, dated May 19, 2022. (For obtaining the procedures
for Bombardier Global Express AFM, Publication No. CSP 700-5000-1V, use
Document Identification No. GL 5000 GVFD AFM.)
     C. Flap Fail (Caution), D. Slat Fail (Caution), E. Slat-
Flap Fail (Caution), and F. Slat Fault (Caution) or Flap Fault
(Caution) or Slat-Flap Fault (Caution) procedures of the Slat and Flap
Control System, Section 05-10, Flight Controls, Chapter 5--Non Normal
Procedure, of the Bombardier Global 5500 AFM, Publication No. CSP 700-
5500-1, Revision 14, dated May 19, 2022. (For obtaining the procedures
for Bombardier Global Express AFM, Publication No. CSP 700-5000-1V, use
Document Identification No. GL 5500 AFM.)
     C. Flap Fail (Caution), D. Slat Fail (Caution), E. Slat-
Flap Fail (Caution), and F. Slat Fault (Caution) or Flap Fault
(Caution) or Slat-Flap Fault (Caution) procedures of the Slat and Flap
Control System, Section 05-10, Flight Controls, Chapter 5--Non Normal
Procedure, of the Bombardier Global 6000 AFM, Publication No. CSP 700-
1V, Revision 42, dated May 19, 2022. (For obtaining the procedures for
Bombardier Global Express AFM, Publication No. CSP 700-1V, use Document
Identification No. GL 6000 AFM.)
     C. Flap Fail (Caution), D. Slat Fail (Caution), E. Slat-
Flap Fail (Caution), and F. Slat Fault (Caution) or Flap Fault
(Caution) or Slat-Flap Fault (Caution) procedures of the Slat and Flap
Control System, Section 05-10, Flight Controls, Chapter 5--Non Normal
Procedure, of the Bombardier Global 6500 AFM, Publication No. CSP 700-
6500-1, Revision 14, dated May 19, 2022. (For obtaining the procedures
for Bombardier Global Express AFM, Publication No. CSP 700-5000-1V, use
Document Identification No. GL 6500 AFM.)
    This service information is reasonably available because the
interested parties have access to it through their normal course of
business or by the means identified in the ADDRESSES section.

Costs of Compliance

    The FAA estimates that this AD affects 450 airplanes of U.S.
registry. The FAA estimates the following costs to comply with this AD:

                                      Estimated Costs for Required Actions
----------------------------------------------------------------------------------------------------------------
                                                                                Cost per       Cost on U.S.
                          Labor cost                              Parts cost        product         operators
----------------------------------------------------------------------------------------------------------------
1 work-hour x $85 per hour = $85.............................              $0              $85          $38,250
----------------------------------------------------------------------------------------------------------------

Authority for This Rulemaking

    Title 49 of the United States Code specifies the FAA's authority to
issue rules on aviation safety. Subtitle I, section 106, describes the
authority of the FAA Administrator. Subtitle VII: Aviation Programs,
describes in more detail the scope of the Agency's authority.
    The FAA is issuing this rulemaking under the authority described in
Subtitle VII, Part A, Subpart III, Section 44701: General requirements.
Under that section, Congress charges the FAA with promoting safe flight
of civil aircraft in air commerce by prescribing regulations for
practices, methods, and procedures the Administrator finds necessary
for safety in air commerce. This regulation is within the scope of that
authority because it addresses an unsafe condition that is likely to
exist or develop on products identified in this rulemaking action.

Regulatory Findings

    This AD will not have federalism implications under Executive Order
13132. This AD will not have a substantial direct effect on the States,
on the relationship between the national government and the States, or
on the distribution of power and responsibilities among the various
levels of government.
    For the reasons discussed above, I certify that this AD:

    (1) Is not a ``significant regulatory action'' under Executive
Order 12866,
    (2) Will not affect intrastate aviation in Alaska, and
    (3) Will not have a significant economic impact, positive or
negative, on a substantial number of small entities under the criteria
of the Regulatory Flexibility Act.

List of Subjects in 14 CFR Part 39

    Air transportation, Aircraft, Aviation safety, Incorporation by
reference, Safety.

The Amendment

    Accordingly, under the authority delegated to me by the
Administrator, the FAA amends 14 CFR part 39 as follows:

PART 39--AIRWORTHINESS DIRECTIVES

0
1. The authority citation for part 39 continues to read as follows:

    Authority:  49 U.S.C. 106(g), 40113, 44701.

Sec.  39.13  [Amended]

0
2. The FAA amends Sec.  39.13 by adding the following new airworthiness
directive:

2023-05-11 Bombardier, Inc.: Amendment 39-22380; Docket No. FAA-
2022-1661; Project Identifier MCAI-2022-00714-T.

(a) Effective Date

    This airworthiness directive (AD) is effective May 12, 2023.

(b) Affected ADs

    None.

(c) Applicability

    This AD applies to Bombardier, Inc., Model BD-700-1A10 and BD-
700-1A11 airplanes, certificated in any category, having serial
numbers 9001 through 9998 inclusive and 60001 through 60097
inclusive.

(d) Subject

    Air Transport Association (ATA) of America Code 27, Flight
controls.

(e) Unsafe Condition

    This AD was prompted by a report that in case of a flap, slat,
or slat-flap failure in flight, resetting the slat flap control unit
(SFCU) to clear the error using the airplane flight manual (AFM)
could result in the stall protection computer (SPC) setting the low-
speed cue to the most conservative stall advance mode. The FAA is
issuing this AD to address a flap, slat, or slat-flap failure
warning. The unsafe condition, if not addressed, could result in
unexpected stall warnings (aural and visual) as well as stick shaker
activation during approach for a landing, increasing flightcrew
workload during a critical phase of flight. The higher landing speed
could consequently require a greater landing distance and possible
diversion to a longer runway.

(f) Compliance

    Comply with this AD within the compliance times specified,
unless already done.

(g) Revision of the Existing AFM

    Within 30 days after the effective date of this AD: Revise the
existing AFM to incorporate the information specified in the AFM
sections of the applicable AFM revisions specified in figure 1 to
paragraph (g) of this AD.

Figure 1 to paragraph (g)--AFM References

[GRAPHIC] [TIFF OMITTED] TR07AP23.012

[GRAPHIC] [TIFF OMITTED] TR07AP23.013

[GRAPHIC] [TIFF OMITTED] TR07AP23.014

(h) Additional AD Provisions

    The following provisions also apply to this AD:
    (1) Alternative Methods of Compliance (AMOCs): The Manager, New
York ACO Branch, FAA, has the authority to approve AMOCs for this
AD, if requested using the procedures found in 14 CFR 39.19. In
accordance with 14 CFR 39.19, send your request to your principal
inspector or responsible Flight Standards Office, as appropriate. If
sending information directly to the manager of the New York ACO
Branch, mail it to ATTN: Program Manager, Continuing Operational
Safety, at the address identified in paragraph (i)(2) of this AD or
email to: [email protected]. If mailing information, also
submit information by email. Before using any approved AMOC, notify
your appropriate principal inspector, or lacking a principal
inspector, the manager of the responsible Flight Standards Office.
    (2) Contacting the Manufacturer: For any requirement in this AD
to obtain instructions from a manufacturer, the instructions must be
accomplished using a method approved by the Manager, New York ACO
Branch, FAA; or Transport Canada; or Bombardier, Inc.'s Transport
Canada Design Approval Organization (DAO). If approved by the DAO,
the approval must include the DAO-authorized signature.

(i) Additional Information

    (1) Refer to Transport Canada AD CF-2022-30, dated June 3, 2022,
for related information. This Transport Canada AD may be found in
the AD docket at regulations.gov under Docket No. FAA-2022-1661.
    (2) For more information about this AD, contact Elizabeth
Dowling, Aerospace Engineer, Mechanical Systems and Administrative
Services Section, FAA, New York ACO Branch, 1600 Stewart Avenue,
Suite 410, Westbury, NY 11590; telephone<PHONE_NUMBER>; email [email protected].

(j) Material Incorporated by Reference

    (1) The Director of the Federal Register approved the
incorporation by reference of the service information listed in this
paragraph under 5 U.S.C. 552(a) and 1 CFR part 51.
    (2) You must use this service information as applicable to do
the actions required by this AD, unless this AD specifies otherwise.
    (i) Slat and Flap Control System, Section 05-10, Flight
Controls, Chapter 5--Non Normal Procedures, of the Bombardier Global
Express AFM, Publication No. CSP 700-1, Revision 112, dated May 19,
2022.
    Note 1 to paragraph (j)(2)(i): For obtaining the procedures for
Bombardier Global Express AFM, Publication No. CSP 700-1, use
Document Identification No. GL 700 AFM-1.

    (ii) Slat and Flap Control System, Section 05-10, Flight
Controls, Chapter 5--Non Normal Procedures, of the Bombardier Global
Express XRS AFM, Publication No. CSP 700-1A, Revision 112, dated May
19, 2022.
    Note 2 to paragraph (j)(2)(ii): For obtaining the procedures for
Bombardier Global Express XRS AFM, Publication No. CSP 700-1A, use
Document Identification No. GL 700 AFM-1A.
    (iii) Slat and Flap Control System, Section 05-10, Flight
Controls, Chapter 5--Non Normal Procedures, of the Bombardier Global
5000 AFM, Publication No. CSP 700-5000-1, Revision 73, dated May 19,
2022.
    Note 3 to paragraph (j)(2)(iii): For obtaining the procedures
for Bombardier Global Express AFM, Publication No. CSP 700-5000-1,
use Document Identification No. GL 5000 AFM.
    (iv) Slat and Flap Control System, Section 05-10, Flight
Controls, Chapter 5--Non Normal Procedures, of the Bombardier Global
5000 AFM, Publication No. CSP 700-5000-1V, Revision 42, dated May
19, 2022.
    Note 4 to paragraph (j)(2)(iv): For obtaining the procedures for
Bombardier Global Express AFM, Publication No. CSP 700-5000-1V, use
Document Identification No. GL 5000 GVFD AFM.
    (v) Slat and Flap Control System, Section 05-10, Flight
Controls, Chapter 5--Non Normal Procedures, of the Bombardier Global
5500 AFM, Publication No. CSP 700-5500-1, Revision 14, dated May 19,
2022.
    Note 5 to paragraph (j)(2)(v): For obtaining the procedures for
Bombardier Global Express AFM, Publication No. CSP 700-5000-1V, use
Document Identification No. GL 5500 AFM.
    (vi) Slat and Flap Control System, Section 05-10, Flight
Controls, Chapter 5--Non Normal Procedures, of the Bombardier Global
6000 AFM, Publication No. CSP 700-1V, Revision 42, dated May 19,
2022.
    Note 6 to paragraph (j)(2)(vi): For obtaining the procedures for
Bombardier Global Express AFM, Publication No. CSP 700-1V, use
Document Identification No. GL 6000 AFM.
    (vii) Slat and Flap Control System, Section 05-10, Flight
Controls, Chapter 5--Non Normal Procedures, of the Bombardier Global
6500 AFM, Publication No. CSP 700-6500-1, Revision 14, dated May 19,
2022.
    Note 7 to paragraph (j)(2)(vii): For obtaining the procedures
for Bombardier Global Express AFM, Publication No. CSP 700-5000-1V,
use Document Identification No. GL 6500 AFM.
    (3) For service information identified in this AD, contact
Bombardier Business Aircraft Customer Response Center, 400
C[ocirc]te-Vertu Road West, Dorval, Qu[eacute]bec H4S 1Y9, Canada;
telephone<PHONE_NUMBER>; email bombardier.com">[email protected]bombardier.com; website
bombardier.com.
    (4) You may view this service information at the FAA,
Airworthiness Products Section, Operational Safety Branch, 2200
South 216th St., Des Moines, WA. For information on the availability
of this material at the FAA, call<PHONE_NUMBER>.
    (5) You may view this service information that is incorporated
by reference at the National Archives and Records Administration
(NARA). For information on the availability of this material at
NARA, email [email protected], or go to: www.archives.gov/federal-register/cfr/ibr-locations.html.

    Issued on March 9, 2023.
Christina Underwood,
Acting Director, Compliance & Airworthiness Division, Aircraft
Certification Service.
[FR Doc. 2023-07134 Filed 4-6-23; 8:45 am]
BILLING CODE 4910-13-P


[Federal Register Volume 88, Number 115 (Thursday, June 15, 2023)]
[Notices]
[Page 39248]
[FR Doc No: 2023-12812]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Project No. 15308-000]

Lock Hydro 10 Partners; Notice of Preliminary Permit Application
Accepted for Filing and Soliciting Comments, Motions To Intervene, and
Competing Applications

    On April 28, 2023, Lock Hydro 10 Partners filed an application for
a preliminary permit, pursuant to section 4(f) of the Federal Power Act
(FPA), proposing to study the feasibility of a hydropower project
located on the Kentucky River, in Clark and Madison Counties, Kentucky.
The sole purpose of a preliminary permit, if issued, is to grant the
permit holder priority to file a license application during the permit
term. A preliminary permit does not authorize the permit holder to
perform any land-disturbing activities or otherwise enter upon lands or
waters owned by others without the owners' express permission.
    The proposed Boonesborough Hydroelectric Project would consist of
the following: (1) an existing 250-foot-long, 35-foot-high concrete
lock and dam; (2) an existing 26.4-mile-long, 596-acre reservoir having
a total capacity of 5,960-acre-feet; (3) a proposed 28-foot-wide, 52-
foot-long, 49-foot-high powerhouse built into the abandoned lock
containing six Voith StreamDiver submersible turbine/generating units
for a total installed capacity of 3.012 megawatts; (4) a proposed 20-
foot-wide, 42-foot-long control building on the adjacent shore; and (5)
a proposed 800-foot-long, 14.0 kilovolt transmission line. The project
is estimated to generate an average of 14,000 megawatt-hours annually.
The existing lock and dam are owned by the Kentucky River Authority.
    Applicant Contact: David Brown Kinloch, Appalachian Hydro
Associate, 414 S Wenzel Street, Louisville, KY 40204; Phone: (502) 589-
0975, or by email at [email protected].
    FERC Contact: Michael Spencer; phone:<PHONE_NUMBER>, or by email
at [email protected].
    Deadline for filing comments, motions to intervene, competing
applications (without notices of intent), or notices of intent to file
competing applications: 60 days from the issuance of this notice.
Competing applications and notices of intent must meet the requirements
of 18 CFR 4.36.
    The Commission's Office of Public Participation (OPP) supports
meaningful public engagement and participation in Commission
proceedings. OPP can help members of the public, including landowners,
environmental justice communities, Tribal members and others, access
publicly available information and navigate Commission processes. For
public inquiries and assistance with making filings such as
interventions, comments, or requests for rehearing, the public is
encouraged to contact OPP at<PHONE_NUMBER> or [email protected].
    The Commission strongly encourages electronic filing. Please file
comments, motions to intervene, notices of intent, and competing
applications using the Commission's eFiling system at https://ferconline.ferc.gov/eFiling.aspx. Commenters can submit brief comments
up to 6,000 characters, without prior registration, using the eComment
system at https://ferconline.ferc.gov/QuickComment.aspx. You must
include your name and contact information at the end of your comments.
For assistance, please contact FERC Online Support at
[email protected],<PHONE_NUMBER> (toll free), or (202) 502-
8659 (TTY). In lieu of electronic filing, you may submit a paper copy.
Submissions sent via the U.S. Postal Service must be addressed to:
Kimberly D. Bose, Secretary, Federal Energy Regulatory Commission, 888
First Street NE, Room 1A, Washington, DC 20426. Submissions sent via
any other carrier must be addressed to: Kimberly D. Bose, Secretary,
Federal Energy Regulatory Commission, 12225 Wilkins Avenue, Rockville,
Maryland 20852. The first page of any filing should include docket
number P-15308-000.
    More information about this project, including a copy of the
application, can be viewed or printed on the ``eLibrary'' link of the
Commission's website at https://elibrary.ferc.gov/eLibrary/search.
Enter the docket number (P-15308) in the docket number field to access
the document. For assistance, contact FERC Online Support.

    Dated: June 9, 2023.
Kimberly D. Bose,
Secretary.
[FR Doc. 2023-12812 Filed 6-14-23; 8:45 am]
BILLING CODE 6717-01-P


[Federal Register Volume 79, Number 140 (Tuesday, July 22, 2014)]
[Notices]
[Pages 42518-42519]
[FR Doc No: 2014-17090]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2014-N-0926]

Advancing the Use of Biomarkers and Pharmacogenomics; Notice of
Public Meeting; Request for Comments

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of public meeting; request for comments.

-----------------------------------------------------------------------

    The Food and Drug Administration (FDA or the Agency) is announcing
a public meeting to discuss current scientific and regulatory
approaches to biomarker development, acceptance, and utility in drug
and biologic (hereafter referred to as therapeutic product) development
programs. The purpose of the public meeting is to initiate constructive
discussion and information sharing on the advancement of biomarker
science in the context of therapeutic product development among
relevant stakeholders. Specifically, the meeting will focus on
identifying challenges for biomarker applications in early- and late-
phase clinical trials and emerging best practices for successful
biomarker-based programs, including codevelopment of in vitro
diagnostic devices and use of biomarkers as outcome measures in
clinical trials. FDA is conducting this meeting in collaboration with
Brookings Institution. This meeting satisfies an FDA commitment that is
part of the fifth authorization of the Prescription Drug User Fee Act
(PDUFA V).
    Date and Time: The meeting will be held on September 5, 2014, from
9 a.m. to 5 p.m.
    Location: The public meeting will be held at the Washington Plaza
Hotel, 10 Thomas Circle NW., Washington, DC 20005. For additional
travel and hotel information, please refer to http://www.brookings.edu/events/2014/09/05-biomarkers-pharmaceutical-FDA. (FDA has verified the
Web site addresses throughout this notice, but FDA is not responsible
for subsequent changes to the Web sites after this document publishes
in the Federal Register).
    Contacts: Padmaja Mummaneni, Food and Drug Administration, Center
for Drug Evaluation and Research, 10903 New Hampshire Ave., Bldg. 51,
Rm. 2164, Silver Spring, MD 20993,<PHONE_NUMBER>, email:
<EMAIL_ADDRESS>or Stephen Ripley, Center for Biologics
Evaluation and Research, Food and Drug Administration, 10903 New
Hampshire Ave., Bldg. 71, Rm. 7301, Silver Spring, MD 20993, 240-402-
7911, email<EMAIL_ADDRESS>    Registration: The meeting venue has limited seating. Individuals
who wish to attend the public meeting must register on or before August
5, 2014, by visiting http://events.SignUp4.com/PDUFAPublic2014. Early
registration is recommended. When registering, please provide the
following information: Name, title, company or organization (if
applicable), postal address, telephone number, and email address.
Registration is free and will be on a first-come, first-served basis.
However, Brookings may limit the number of participants from each
organization based on space limitations. Onsite registration on the day
of the meeting by Brookings will be based on space availability.
    If you need special accommodations because of disability, please
contact Joanna Klatzman at the Brookings Institution (email:
<EMAIL_ADDRESS>at least 7 days before the meeting.
    Streaming Webcast of the Public Meeting: A live Webcast of this
meeting will be viewable at http://www.brookings.edu/events/2014/09/05-biomarkers-pharmaceutical-FDA on the day of the meeting. A video record
of the meeting will be available at the same Web address for 1 year.
    Comments: Regardless of attendance at the public meeting,
interested persons may submit electronic comments to http://www.regulations.gov or written comments to the Division of Dockets
Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane,
Rm. 1061, Rockville, MD 20852. It is only necessary to send one set of
comments. Identify all comments with the corresponding docket number
found in brackets in the heading of this document. To ensure
consideration, submit comments by November 5, 2014. Received comments
may be seen in the Division of Dockets Management between 9 a.m. and 4
p.m., Monday through Friday, and will be posted to the docket at http://www.regulations.gov.
    Transcripts: Please be advised that as soon as a transcript is
available, it will be accessible at http://www.regulations.gov. It may
be viewed at the Division of Dockets Management (see Comments). A
transcript will also be available in either hard copy or on CD-ROM,
after submission of a Freedom of Information request. Written requests
are to be sent to Division of Freedom of Information (ELEM-1029), Food
and Drug Administration, 12420 Parklawn Dr, Element Bldg., Rockville,
MD 20857.

SUPPLEMENTARY INFORMATION:

I. Background

    On July 9, 2012, the President signed into law the Food and Drug
Administration Safety and Innovation Act (FDASIA) (Pub. L. 112-144).
Title I of FDASIA reauthorizes PDUFA and provides FDA with the user fee
resources necessary to maintain an efficient review process for human
drug and biological products. The reauthorization of PDUFA includes
performance goals and procedures for

the Agency that represents FDA's commitments during fiscal years 2013-
2017. These commitments are fully described in the document entitled
``PDUFA Reauthorization Performance Goals and Procedures Fiscal Years
2013 through 2017'' (``PDUFA Goals Letter''), available on FDA's Web
site at http://www.fda.gov/downloads/ForIndustry/UserFees/PrescriptionDrugUserFee/UCM270412.pdf. Section IX of the PDUFA Goals
Letter, titled Enhancing Regulatory Science and Expediting Drug
Development,'' includes an enhancement to advance the use of biomarkers
and pharmacogenomics. As part of this enhancement, FDA committed to
hold a public meeting to discuss the current status of biomarkers and
pharmacogenomics and potential strategies to facilitate scientific
exchanges in regulatory and non-regulatory contexts. The public meeting
announced by this notice will fulfill this commitment.

II. Purpose and Scope of the Meeting

    The objectives of the meeting are as follows:
     Initiate constructive discussion and information-sharing
about challenges and best practices in biomarker acceptance and utility
in the context of therapeutic product development programs,
     share current experience regarding critical issues in the
transition of exploratory biomarkers to their use in clinical trial
design and analysis plans, including best practices in the coordination
of codevelopment of therapeutic products with in vitro diagnostic
devices, and
     obtain input on evidentiary criteria for biomarkers as
outcome measures in clinical trials.
    Although many external stakeholders propose using predictive,
prognostic, pharmacodynamic, or surrogate biomarkers to enhance
therapeutic product development, the scientific rationale, quality, and
quantity of supportive data to support the transition from exploratory
studies to confirmatory trials are variable. This meeting will discuss
common uses of biomarkers in therapeutic product development programs.
Discussion topics include specific considerations for early- and late-
phase clinical trials when employing biomarker-based trial designs,
emerging best practices in codevelopment of therapeutic products with
in vitro diagnostic devices, and discussion of context-specific
scenarios in which biomarkers may be used as outcome measures.
    The public input from the meeting will be used to identify
opportunities for biomarker-related regulatory guidance, improve
understanding and consistency in regulatory review of therapeutic
product applications that incorporate biomarkers in clinical trial
designs, and identify potential strategies to facilitate scientific
exchanges in regulatory and non-regulatory contexts.

III. Scope of Public Input Requested

    FDA seeks input on a range of topics related to common challenges
and emerging strategies for application of biomarkers in clinical
trials, whether for patient selection or as an outcome measure in
therapeutic product development. Potential topics for discussion
include the following:

1. Critical Issues in the Transition of Exploratory Biomarkers to
Companion Diagnostic Devices

     Early-phase trial designs and exploratory biomarker
analysis approaches to effectively inform whether biomarker-enriched
confirmatory trial strategies or other strategies are appropriate,
     evidentiary standards for incorporating novel biomarkers
into the design and analysis of pre-marketing confirmatory trials
(e.g., for patient selection), and need for and timing of data
collection in non-targeted populations,
     prospective/retrospective approaches to validate
biomarkers in the context of confirmatory trials,
     approaches to establish and modify thresholds for
quantitative biomarkers prior to conducting confirmatory trials,
     best practices for biospecimen collection and in vitro
diagnostic assay development in early-phase therapeutic trials to
support subsequent biomarker/diagnostic codevelopment,
     best practices for effective communication between
regulatory agencies and therapeutic or diagnostic sponsors in the
setting of codevelopment, and
     codevelopment considerations for biomarkers that are
predictive, but not necessarily essential to the safe and effective use
of the therapeutic product.

2. Use of a Biomarker as a Clinical Trial Outcome Measure

     Criteria for consideration of biomarker outcomes in
clinical trials as correlates,
     principles to consider for biomarker outcomes as
replacement endpoints of clinical endpoints considering the following:
    [cir] Multiple causal pathways of a disease process,
    [cir] biomarker endpoint is not in the causal pathway of the
disease process,
    [cir] interventions with mechanisms of action independent of the
disease process,
     evidence for a compelling context for the use of a
biomarker as a surrogate endpoint, and
     roles, if any, on metaanalysis of clinical trials data to
establish the utility of biomarker outcomes as surrogates.
    In this Federal Register notice, FDA has included specific issues
that will be addressed by the presenters and panelists. Time will be
reserved during the meeting for general comments and questions from the
audience following the panel discussions. FDA will do its best to
accommodate requests to speak.
    The agenda and background materials will be available approximately
2 weeks before the meeting at http://www.brookings.edu/events/2014/09/05-biomarkers-pharmaceutical-FDA.

    Dated: July 16, 2014.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2014-17090 Filed 7-21-14; 8:45 am]
BILLING CODE 4164-01-P


[Federal Register Volume 84, Number 96 (Friday, May 17, 2019)]
[Notices]
[Pages 22488-22489]
[FR Doc No: 2019-10303]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Project No. 2275-049]

Public Service Company of Colorado; Notice of Application
Accepted for Filing and Soliciting Comments, Motions to Intervene,
Protests, Recommendations, and Terms and Conditions

    Take notice that the following hydroelectric application has been
filed with the Commission and is available for public inspection:
    a. Application Type: Non-Capacity Amendment of License.
    b. Project No: 2275-049.
    c. Date Filed: March 21, 2019.
    d. Applicant: Public Service Company of Colorado.
    e. Name of Project: Salida Hydroelectric Project Numbers 1 and 2.
    f. Location: The project is located on the South Fork Arkansas
River in Chaffee County, Colorado.
    g. Filed Pursuant to: Federal Power Act, 16 U.S.C. 791a-825r.
    h. Applicant Contact: Christine E. Johnston, Project Manager; (303)
294-2224<EMAIL_ADDRESS>    i. FERC Contact: Krista Sakallaris;<PHONE_NUMBER>;
<EMAIL_ADDRESS>    j. Deadline for filing motions to intervene and protests, comments,
recommendations, and terms and conditions, is 60 days from the issuance
date of this notice by the Commission; reply comments are due 105 days
from the issuance date of this notice by the Commission. The Commission
strongly encourages electronic filing.
    The Commission strongly encourages electronic filing. Please file
comments, motions to intervene, and protests using the Commission's
eFiling system at http://www.ferc.gov/docs-filing/efiling.asp.
Commenters can submit brief comments up to 6,000 characters, without
prior registration, using the eComment system at http://www.ferc.gov/docs-filing/ecomment.asp. You must include your name and contact
information at the end of your comments. For assistance, please contact
FERC Online Support at<EMAIL_ADDRESS>(866) 208-3676 (toll
free), or<PHONE_NUMBER> (TTY). In lieu of electronic filing, please
send a paper copy to: Secretary, Federal Energy Regulatory Commission,
888 First Street NE, Washington, DC 20426. The first page of any filing
should include docket number P-2275-049. Comments emailed to Commission
staff are not considered part of the Commission record.
    The Commission's Rules of Practice and Procedure require all
intervenors filing documents with the Commission to serve a copy of
that document on each person whose name appears on the official service
list for the project. Further, if an intervenor files comments or
documents with the Commission relating to the merits of an issue that
may affect the responsibilities of a particular resource agency, they
must also serve a copy of the document on that resource agency.
    k. Description of Request: Public Service Company of Colorado is
requesting Commission approval to amend its license to remove the
facilities and land within the project boundary associated with Salida
Unit 1. As proposed, the Garfield Dam would be removed along with
associated structures and the upstream area will be restored to provide
a stable channel and habitat for fish and macroinvertebrates. Portions
of the Garfield dam to Fooses Reservoir Gravity Pipeline will be
removed while the rest will be decommissioned and left in place. The
Fooses Dam will be removed along with some auxiliary structures and the
stream channel of Fooses Creek will be restored. The above ground
sections of the Fooses Bypass Pipeline will be removed and the
underground sections will be decommissioned and left in place. The
Salida No. 1 penstock and pipeline will be decommissioned and portions
located on U.S. Forest Service land and private property will be left
in place. The Salida No. 1 powerhouse will either be sold or removed
and the non-project substation within the current project boundary will
be removed. The proposal includes removing approximately 21 acres of
U.S Forest Service land and 3.6 acres of private land from the project
boundary to eliminate lands that encompass the above facilities. As
proposed, the project's installed capacity would be reduced from 1.31
megawatts to 560 kilowatts. The proposed amendment would not have any
effect on the Salida Unit 2 portion of the project, which will continue
to operate as licensed.
    l. Locations of the Application: A copy of the application is
available for inspection and reproduction at the Commission's Public
Reference Room, located at 888 First Street NE, Room 2A, Washington, DC
20426, or by calling<PHONE_NUMBER>. This filing may also be viewed on
the Commission's website at http://www.ferc.gov using the ``eLibrary''
link. Enter the docket number excluding the last three digits in the
docket number field to access the document. You may also register
online at http://www.ferc.gov/docs-filing/esubscription.asp to be
notified via email of new filings and issuances related to this or
other pending projects. For assistance, call 1-866-208-3676 or email
<EMAIL_ADDRESS>for TTY, call<PHONE_NUMBER>. A copy is
also available for inspection and reproduction at the address in item
(h) above. Agencies may obtain copies of the application directly from
the applicant.
    m. Individuals desiring to be included on the Commission's mailing
list should

so indicate by writing to the Secretary of the Commission.
    n. Comments, Protests, or Motions to Intervene: Anyone may submit
comments, a protest, or a motion to intervene in accordance with the
requirements of Rules of Practice and Procedure, 18 CFR 385.210, .211,
.214, respectively. In determining the appropriate action to take, the
Commission will consider all protests or other comments filed, but only
those who file a motion to intervene in accordance with the
Commission's Rules may become a party to the proceeding. Any comments,
protests, or motions to intervene must be received on or before the
specified comment date for the particular application.
    o. Filing and Service of Documents: Any filing must (1) bear in all
capital letters the title ``COMMENTS'', ``PROTEST'', ``MOTION TO
INTERVENE'', ``RECOMMENDATIONS'', or ``TERMS AND CONDITIONS'' as
applicable; (2) set forth in the heading the name of the applicant and
the project number of the application to which the filing responds; (3)
furnish the name, address, and telephone number of the person
commenting, protesting or intervening; and (4) otherwise comply with
the requirements of 18 CFR 385.2001 through 385.2005. All comments,
motions to intervene, or protests must set forth their evidentiary
basis. Any filing made by an intervenor must be accompanied by proof of
service on all persons listed in the service list prepared by the
Commission in this proceeding, in accordance with 18 CFR 385.2010.

    Dated: May 13, 2019.
Kimberly D. Bose,
Secretary.
[FR Doc. 2019-10303 Filed 5-16-19; 8:45 am]
BILLING CODE 6717-01-P